ReviewCyborg and bionic systems (Washington, D.C.)2026
Embodied Cross-Domain Intelligence in Biomedical Microrobots: A Review.
Review in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Magnetic nanorobots in oncology: From targeted drug delivery to smart theranostic systems.Materials today. Bio · 2026Review
- Magnetic/photothermal dual-driven micro/nanorobots for synergistic NO-mediated photothermal thrombolysis.Materials today. Bio · 2026Article
- Autonomous Microrobots for Spatiotemporally Active Therapeutic Delivery and Controlled Release.Cyborg and bionic systems (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microrobots are emerging as transformative tools for biomedical applications, including minimally invasive diagnostics, targeted therapy, and microsurgical intervention. However, achieving reliable performance and adaptation to diverse tasks and environments requires capabilities that exceed any single form of intelligence. Here, we introduce embodied cross-domain intelligence, a framework for synergistic coupling across physical, biological, computational, and human intelligence, enabling multifunctional, collaborative, and adaptive microrobotic behavior in dynamic, safety-critical biological settings. Unlike prior reviews that address these intelligence domains in isolation, this review aims to provide a unified framework, outlining each domain's principles, recent advances, and limitations; analyzing the interfaces that foster synergy; and mapping representative domain combinations to major biomedical applications. We further identify core challenges in integration, control, safety, and validation and outline future research directions to accelerate clinical translation. By framing biomedical microrobot development as a cross-domain synergy challenge, this review aims to guide interdisciplinary efforts toward systems capable of executing complex, multistage tasks across their operational life cycle. The associated project is available on the online project page (https://nuounuou.github.io/Embodied-Cross-Domain-Intelligence-in-Biomedical-Microrobots-A-Review/).
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.